Skip to Content

Pfizer STN 50 mg (Sutent 50 mg)

Generic Name: sunitinib

Pill with imprint Pfizer STN 50 mg is Brown, Capsule-shape and has been identified as Sutent 50 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.

Sutent is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer STN 50 mg

Sutent 50 mg Pfizer STN 50 mg
Sutent 50 mg Pfizer STN 50 mg Front
Sutent 50 mg Pfizer STN 50 mg Back
Sutent 50 mg Pfizer STN 50 mg

Sutent

Generic Name
sunitinib
Imprint
Pfizer STN 50 mg
Strength
50 mg
Color
Brown
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer U.S. Pharmaceuticals Group
National Drug Code (NDC)
00069-0980
Inactive Ingredients
mannitol, croscarmellose sodium, povidone k25, magnesium stearate, titanium dioxide, ferric oxide red, ferric oxide yellow, ferrosoferric oxide, shellac, propylene glycol, sodium hydroxide, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.